M. E. T Butarbutar et al / Indo J Pharm 1 (2020) 55-68
66
20. Mehenni L, Lahiani-Skiba M, Ladam G,
Hallouard F, Skiba M. Preparation and
Characterization of Spherical Amorphous Solid
Dispersion with Amphotericin B.
Pharmaceutics. 2018;10(4):235.
21. Li Y, He ZD, Zheng QE, Hu C, Lai WF.
Hydroxypropyl-β-cyclodextrin for delivery of
baicalin via inclusion complexation by
supercritical fluid encapsulation. Molecules.
2018;23(5).
22. Milovanovic S, Djuris J, Dapčević A,
Medarevic D, Ibric S, Zizovic I. Soluplus
®
,
Eudragit
®
, HPMC-AS foams and solid
dispersions for enhancement of Carvedilol
dissolution rate prepared by a supercritical CO
2
process. Vol. 76, Polymer Testing. Elsevier Ltd;
2019. 54–64 p.
23. Lu J, Cuellar K, Hammer NI, Jo S, Gryczke A,
Kolter K, et al. Solid-state characterization of
Felodipine-Soluplus amorphous solid
dispersions. Drug Dev Ind Pharm.
2016;42(3):485–96.
24. Zheng K, Lin Z, Capece M, Kunnath K, Chen L,
Davé RN. Effect of Particle Size and Polymer
Loading on Dissolution Behavior of Amorphous
Griseofulvin Powder. J Pharm Sci.
2019;108(1):234–42.
25. Altamimi MA, Elzayat EM, Qamar W, Alshehri
SM, Sherif AY, Haq N, et al. Evaluation of the
bioavailability of hydrocortisone when prepared
as solid dispersion. Saudi Pharm J. 2019;
26. Ziaee A, O’Dea S, Howard-Hildige A, Padrela
L, Potter C, Iqbal J, et al. Amorphous solid
dispersion of ibuprofen: A comparative study on
the effect of solution based techniques. Int J
Pharm. 2019;118816.
27. Khatri P, Shah MK, Patel N, Jain S, Vora N, Lin
S. Preparation and characterization of
pyrimethamine solid dispersions and an
evaluation of the physical nature of
pyrimethamine in solid dispersions. J Drug
Deliv Sci Technol. 2018;45:110–23.
28. Indulkar AS, Lou X, Zhang GGZ, Taylor LS.
Insights into the Dissolution Mechanism of
Ritonavir-Copovidone Amorphous Solid
Dispersions: Importance of Congruent Release
for Enhanced Performance. Vol. 16, Molecular
Pharmaceutics. 2019. 1327–1339 p.
29. Milne M, Liebenberg W, Aucamp M. The
Stabilization of Amorphous Zopiclone in an
Amorphous Solid Dispersion. AAPS
PharmSciTech. 2015;16(5):1190–202.
30. Ma X, Williams RO. Characterization of
amorphous solid dispersions: An update. J Drug
Deliv Sci Technol. 2019;50(November
2018):113–24.
31. Li J, Fan N, Li C, Wang J, Li S, He Z. The
tracking of interfacial interaction of amorphous
solid dispersions formed by water-soluble
polymer and nitrendipine. Appl Surf Sci.
2017;420:136–44.
32. Lust A, Strachan CJ, Veski P, Aaltonen J,
Heinämäki J, Yliruusi J, et al. Amorphous solid
dispersions of piroxicam and Soluplus
®
:
Qualitative and quantitative analysis of
piroxicam recrystallization during storage. Int J
Pharm. 2015;486(1–2):306–14.
33. Paudel A, Geppi M, Van Den Mooter G.
Structural and dynamic properties of amorphous
solid dispersions: The role of solid-state nuclear
magnetic resonance spectroscopy and
relaxometry. J Pharm Sci. 2014;103(9):2635–
62.
34. Yuan X, Sperger D, Munson EJ. Investigating
miscibility and molecular mobility of
nifedipine-PVP amorphous solid dispersions
using solid-state NMR spectroscopy. Mol
Pharm. 2014;11(1):329–37.
35. Tombari E, Ferrari C, Johari GP, Shanker RM.
Calorimetric relaxation in pharmaceutical
molecular glasses and its utility in
understanding their stability against
crystallization. J Phys Chem B.
2008;112(35):10806–14.
36. Lahiani-Skiba M, Hallouard F, Bounoure F,
Milon N, Karrout Y, Skiba M. Enhanced
Dissolution and Oral Bioavailability of
Cyclosporine A: Microspheres Based on αβ-
Cyclodextrins Polymers. Pharmaceutics.
2018;10(4):285.
37. Guo Y, Shalaev E, Smith S. Physical stability of
pharmaceutical formulations: Solid-state